Navigation Links
Public attitudes to new technology: Lessons for regulators

(Santa Barbara, California) New technologies may change our lives for the better, but sometimes they have risks. Communicating those benefits and risks to the public, and developing regulations to deal with them, can be difficult particularly if there's already public opposition to the technology.

A new study that provides an overview of research on public perceptions of nanotechnology technology on a very, very small scale challenges some current ideas of how people view the risks and benefits of new technology. The work has implications for how policymakers talk about and regulate new technologies.

Public views on nanotechnology, which could revolutionize medicine, electronics and energy technology, but has possible health and environmental risks, are overwhelmingly favorable, the study found. However many people hadn't heard of nanotechnology, and nearly half those surveyed in North America, Europe and Japan weren't sure what they thought of it. It's reassuring that those people haven't made hasty judgments, the authors say, but that means that bungled attempts to educate the public about nanotechnology, or to regulate it, could turn public opinion against this promising technology.

"If you only talk about benefits it doesn't mean the public will buy the product and everyone lives happily ever after. We know that is not a good scenario," says Barbara Herr Harthorn, Director and Principal Investigator of the National Science Foundation-funding Center for Nanotechnology in Society at the University of California, Santa Barbara (CNS-UCSB).

Harthorn is one of the authors of a study "Anticipating the perceived risk of nanotechnologies" appearing online Sept. 20 in the journal Nature Nanotechnology. It is based on data from 22 surveys conducted over the last decade.

Previous studies have found that new and unknown technologies such as biotechnology tend to be regarded as risky, but that's not the case for nanotechnology, according to this research. People who thought nanotechnology had more benefits than risks outnumbered those who perceived greater risks by 3 to 1 in this study. The 44 percent of people who didn't have an opinion either way surprised the researchers.

"You don't normally get that reluctance," says Terre Satterfield of the University of British Columbia in Canada, lead author of the study and a collaborator with CNS-UCSB.

It's important to study how people perceive risk, and not just expert assessments of actual risk, Herr Harthorn says, because it's "a much better way to understand how people are going to behave and respond."

"It's not true that if a technology has benefits it will automatically get accepted by the public," adds Milind Kandlikar of the University of British Columbia. He is also a collaborator with CNS-UCSB and a co-author of the study, along with Joseph Conti, a former graduate fellow with CNS-UCSB, and Christian Beaudrie of the University of British Columbia.

Public perceptions of risk depend on various demographic and cultural factors; for example, wealthy, well-educated white men tend to think of new technologies as less risky. Public opinion also is easily swayed by catastrophic events like the Chernobyl accident, which galvanized opposition to nuclear power, and by news like reports of deaths from Bovine spongiform encephalopathy (BSE) in Europe, or from severe acute respiratory syndrome (SARS) or swine flu (the H1N1 virus).

"It's much easier to destroy trust than gain it," Satterfield says, so after an event like a nuclear meltdown or oil spill, leaders need to "take responsibility for any consequences quickly and clearly."

Because nanotechnology hasn't made big news, it offers researchers a chance to study how people judge new technology before controversy arises. "The future is yet to be written. Judgments could go either way," Satterfield says.


Contact: Barbara Herr Harthorn
University of California - Santa Barbara

Related biology technology :

1. Omeros Commences Initial Public Offering of Common Stock
2. Rigel Announces Pricing of Public Offering of 13,000,000 Shares of Common Stock
3. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) is Feasible in Patients Requiring Undeferrable Non-Cardiac Surgery, International Journal of Cardiology Publication Reports
4. Greenway Medical Technologies Plays Leading Role in Interoperability Demonstrations at Seventh Annual Public Health Information Network (PHIN) Conference
5. Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company
6. Accera Announces Peer-Reviewed Publication of the Results of its 90-Day Clinical Study of AC-1202 (Axona(TM) ) in Mild to Moderate Alzheimers Disease
7. Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock
8. Micromet Closes $80.5 Million Public Offering of Common Stock
9. Human Genome Sciences Announces Closing of Public Offering
10. Micromet Announces Pricing of Public Offering of Common Stock
11. Micromet Announces Public Offering of Common Stock
Post Your Comments:
(Date:11/30/2015)... -- Champions Oncology, Inc. (CSBR), engaged in the development of ... and use of oncology drugs, today announced that ... at the LD MICRO Investor Conference on Wednesday, December ... conference, held at the Luxe Sunset Bel Air Hotel ... feature 200 small/micro-cap companies and is expected to host ...
(Date:11/30/2015)...  HUYA Bioscience International, the leader in accelerating global ... today announced it has signed a Memorandum of Understanding ... collaboration between KDDF and HUYA with the ultimate goal ... for the global market. China,s ... innovative preclinical and clinical stage compounds. The company advances ...
(Date:11/30/2015)... Germany , November 30, 2015 ... Vienna, Austria to be held December 1-4, ... in Vienna, Austria to be ... owned subsidiary of Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), announced ... Therapy Suite at the 3rd European Congress of NeuroRehabilitation ...
(Date:11/30/2015)... PETACH TIKVAH, Israel , Nov. 30, 2015 ... ), a leading developer of adult stem cell technologies for ... Therapeutics Ltd., has been awarded an additional grant of approximately ... Chief Scientist (OCS). This grant, the second this year, brings ... to approximately $1.8 million (approximately NIS7 million).  ...
Breaking Biology Technology:
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
(Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
(Date:10/26/2015)... and LAS VEGAS , ... Nok Labs , an innovator in modern authentication and ... today announced the launch of its latest version of ... platform enabling organizations to use standards-based authentication that supports ... Nok S3 Authentication Suite is ideal for organizations deploying ...
Breaking Biology News(10 mins):